Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$859M |
| 2 |
Progressive
PGR
|
$429M |
| 3 |
Netflix
NFLX
|
$368M |
| 4 |
Danaher
DHR
|
$364M |
| 5 |
Adobe
ADBE
|
$343M |
Top Sells
| 1 |
Advanced Micro Devices
AMD
|
$710M |
| 2 |
Microsoft
MSFT
|
$619M |
| 3 |
NVIDIA
NVDA
|
$447M |
| 4 |
Eli Lilly
LLY
|
$391M |
| 5 |
AbbVie
ABBV
|
$373M |
Sector Composition
| 1 | Technology | 32.66% |
| 2 | Healthcare | 19.35% |
| 3 | Industrials | 10.04% |
| 4 | Financials | 10% |
| 5 | Consumer Discretionary | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Zymeworks
ZYME
$1.14B
| $160K | ﹤0.01% |
18,547
-20,347
| -52% | -$176K |
|
|
ONL
2502
Orion Office REIT
ONL
$170M
| $160K | ﹤0.01% |
24,183
-58
| -0.2% | -$383 |
|
2503
Aurora
AUR
$10.6B
| $158K | ﹤0.01% |
54,263
-512
| -0.9% | -$1.5K |
|
|
LGTY
2504
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $157K | ﹤0.01% |
14,946
-17
| -0.1% | -$179 |
|
2505
Invesco Mortgage Capital
IVR
$529M
| $157K | ﹤0.01% |
13,661
+17
| +0.1% | +$195 |
|
2506
Lindblad Expeditions
LIND
$803M
| $156K | ﹤0.01% |
14,370
-15
| -0.1% | -$163 |
|
|
QVCGA
2507
QVC Group, Inc. Series A Common Stock
QVCGA
$73.3M
| $155K | ﹤0.01% |
3,080
-3
| -0.1% | -$151 |
|
2508
Grid Dynamics Holdings
GDYN
$662M
| $152K | ﹤0.01% |
16,482
-18
| -0.1% | -$166 |
|
2509
OraSure Technologies
OSUR
$236M
| $152K | ﹤0.01% |
30,421
-38
| -0.1% | -$190 |
|
|
CTEV
2510
Claritev Corporation
CTEV
$1.15B
| $152K | ﹤0.01% |
1,807
-19
| -1% | -$1.6K |
|
|
ICPT
2511
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $151K | ﹤0.01% |
13,699
-21
| -0.2% | -$232 |
|
2512
Mercer International
MERC
$216M
| $150K | ﹤0.01% |
18,650
| – | – |
|
2513
SiriusXM
SIRI
$8.1B
| $149K | ﹤0.01% |
3,285
-69,427
| -95% | -$3.15M |
|
2514
Emergent Biosolutions
EBS
$404M
| $149K | ﹤0.01% |
20,304
-44
| -0.2% | -$323 |
|
|
PTVE
2515
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $149K | ﹤0.01% |
19,707
| – | – |
|
|
SLGC
2516
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $149K | ﹤0.01% |
64,509
-1,673,305
| -96% | -$3.86M |
|
2517
Flushing Financial
FFIC
$457M
| $147K | ﹤0.01% |
11,937
-17
| -0.1% | -$209 |
|
2518
ARS Pharmaceuticals
SPRY
$995M
| $147K | ﹤0.01% |
+21,879
| New | +$147K |
|
2519
Pennant Group
PNTG
$840M
| $147K | ﹤0.01% |
11,939
-15
| -0.1% | -$184 |
|
|
ALLK
2520
DELISTED
Allakos
ALLK
| $146K | ﹤0.01% |
33,539
-102
| -0.3% | -$444 |
|
2521
AMC Networks
AMCX
$328M
| $145K | ﹤0.01% |
12,144
-6
| -0% | -$72 |
|
2522
Bridgewater Bancshares
BWB
$442M
| $145K | ﹤0.01% |
14,681
-157
| -1% | -$1.55K |
|
2523
Westrock Coffee
WEST
$498M
| $144K | ﹤0.01% |
13,263
-87
| -0.7% | -$945 |
|
2524
Alector
ALEC
$305M
| $142K | ﹤0.01% |
23,702
-34
| -0.1% | -$204 |
|
2525
MaxCyte
MXCT
$150M
| $140K | ﹤0.01% |
30,624
-83
| -0.3% | -$381 |
|